Syntekabio collaborates with global compound supplier Enamine for AI-based synthetic drug development
KYIV, UKRAINE, September 2, 2024 /EINPresswire.com/ -- Syntekabio collaborates with global compound supplier Enamine on AI-driven synthetic drug development and global market expansion through a strategic partnership. Syntekabio (CEO Jongsun Jung, …